QUANTITY

​

QUALITY

We’ve created a better database of healthcare M&A data for PE firms, health systems, investment bankers, valuators, attorneys, and dealmakers of all kinds.

HEALTHCARE M&A DATA THAT EXCELS

Click through for more segments

1,400+

Healthcare services transactions since 2010 with deal values and revenue/EBITDA multiples

Ambulatory Surgery Centers

73 with revenue or EBITDA multiples

62 with EBITDA multiples

​

 

​

QUALITY INFORMATION IS GOOD FOR YOU

There’s more publicly-available private market data with reliable deal values and multiples in healthcare than any other industry, it just takes a heavy lift to find it. We maintain a database of links to our sources, which include:
​
   •  Fairness opinions

   •  SEC filings

   •  Press releases

   •  Bond market research

   •  Medicare cost reports

   •  CON filings (FOIA)

   •  Form 990s

   •  Public financial statements

   •  AG reports

   •  Insurance department filings

​

ACCURATE

DATA

SIMPLE

FORMAT

AMPLE

DETAIL

RELIABLE

SOURCES

MORE DATA, MORE POSSIBILITES

What could your team do with better market data?

CHOOSE YOUR TREATMENT PLAN

1

Annual Subscriptions

24/7 access to entire database

Give your entire team 24/7 access to up-to-date research across all industry segments we cover.

 

For healthcare M&A professionals of all kinds

REQUEST DEMO

2

Individual Reports

Only the segments you want

One-time purchases by the segment to get your team up to speed quickly for specific projects.

​

For single-use client chargeable projects

VIEW REPORTS

ANATOMY OF OUR ANALYSIS

Ensure deal value is accurately stated on a total invested capital basis

​Source reliable indications of revenue and EBITDA

Share the resulting

data in an easy to use format with links to sources

U.S. Renal Care

 

  • In February 2019 a group of private equity sponsors agreed to a leveraged buyout of U.S. Renal Care for a total valuation of $2.7b, according to Moody's​​

​

  • U.S. Renal Care’s FY 2018 financial statements, including adjusted EBITDA (less payments to minority investors in subsidiaries) were disclosed publicly in a New York certificate of need filing​​

​Source Documents 

Bond Rating Release

CON Filing

Enterprise Value:  $2.7b

 

Revenue Multiple:   2.0x

 

EBITDA Multiple:     9.3x

WE SUPPORT IMPROVED OUTCOMES

Private Equity Firms

Know your market. Scope's research arms you with more healthcare private market data than anyone else, so your analysts can track industry-wide valuations and easily compare market segments.

Valuation Consulting

Never rely solely on the income approach again. Scope's research makes reliable comparable transaction data readily available so you can develop better supported conclusions.

​

Corporate Development

The best strategy is an informed one. Scope's research lets your team to dig deeper into specific transactions in your target market to understand how deals are priced and structured.

Attorneys

Always know the facts. Scope's research enables your firm to provide more knowledgeable negotiation support, resolve disputes with facts rather than opinions, and review valuation reports like a pro.

Investment Bankers

Precedent transactions in a minute. Scope's research allows your analysts to visualize market trends at a high-level, get up-to-speed on new segments quickly, and re-focus time on getting the right deal done.

SEE FOR YOURSELF

Scope Research was created by Will Hamilton, a healthcare valuation expert who long suffered from a lack of publicly available healthcare transaction data. Our demos are low pressure, customized, and interactive so you always see what you need to see in the time that you have.
  • Grey LinkedIn Icon

© 2021 BY SCOPE RESEARCH